FI69069C - Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner Download PDF

Info

Publication number
FI69069C
FI69069C FI781737A FI781737A FI69069C FI 69069 C FI69069 C FI 69069C FI 781737 A FI781737 A FI 781737A FI 781737 A FI781737 A FI 781737A FI 69069 C FI69069 C FI 69069C
Authority
FI
Finland
Prior art keywords
formula
cyano
methyl
ethyl
compound
Prior art date
Application number
FI781737A
Other languages
English (en)
Finnish (fi)
Other versions
FI69069B (fi
FI781737A (fi
Inventor
Ronnie Ray Crenshaw
George Michael Luke
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/848,959 external-priority patent/US4112234A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI781737A publication Critical patent/FI781737A/fi
Priority to FI831755A priority Critical patent/FI831755L/fi
Publication of FI69069B publication Critical patent/FI69069B/fi
Application granted granted Critical
Publication of FI69069C publication Critical patent/FI69069C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI781737A 1977-06-03 1978-05-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner FI69069C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI831755A FI831755L (fi) 1977-06-03 1983-05-18 Vid framstaellning av terapeutisk anvaendbara n-cyan-n'-/ 2-/(4-metyl-5-imidazolyl)metyltio/etyl /-n -alkymylguanilider anvaendbara mellan produkter

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80300977A 1977-06-03 1977-06-03
US80300977 1977-06-03
US82679677A 1977-08-22 1977-08-22
US82679677 1977-08-22
US05/848,959 US4112234A (en) 1977-08-22 1977-11-07 Imidazolylmethylthioethyl alkynyl guanidines
US84895977 1977-11-07

Publications (3)

Publication Number Publication Date
FI781737A FI781737A (fi) 1978-12-04
FI69069B FI69069B (fi) 1985-08-30
FI69069C true FI69069C (fi) 1985-12-10

Family

ID=27419995

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781737A FI69069C (fi) 1977-06-03 1978-05-31 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner

Country Status (26)

Country Link
JP (1) JPS543067A (el)
AR (2) AR222797A1 (el)
CA (1) CA1110251A (el)
CH (2) CH641167A5 (el)
CY (3) CY1231A (el)
DD (1) DD140038A5 (el)
DE (1) DE2824066A1 (el)
DK (1) DK243178A (el)
ES (3) ES470474A1 (el)
FI (1) FI69069C (el)
FR (2) FR2401143A1 (el)
GB (3) GB1598629A (el)
GR (1) GR73860B (el)
HK (3) HK38184A (el)
HU (1) HU186766B (el)
IE (1) IE47543B1 (el)
IL (1) IL54819A (el)
KE (1) KE3373A (el)
LU (1) LU79725A1 (el)
MY (3) MY8500451A (el)
NL (1) NL7805935A (el)
NO (3) NO152214C (el)
NZ (1) NZ187376A (el)
SE (3) SE443784B (el)
SG (1) SG8584G (el)
YU (4) YU129778A (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
US4339439A (en) * 1981-01-19 1982-07-13 Bristol-Myers Company Pharmaceutical methods and compositions
JPS57134318A (en) * 1981-02-12 1982-08-19 Nissan Motor Co Ltd Air mixing construction of air conditioner
JPS5848516U (ja) * 1981-09-30 1983-04-01 日産車体株式会社 車両用空気調和装置
JPS6018010U (ja) * 1983-07-18 1985-02-07 日産自動車株式会社 車両用空気調和装置の温度調整機構
JPS60113211U (ja) * 1984-01-06 1985-07-31 松下電器産業株式会社 自動車用空気調和装置
ES2007948A6 (es) * 1988-07-06 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados propargilguanidicos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024271A (en) * 1971-03-09 1977-05-17 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1531221A (en) * 1974-09-02 1978-11-08 Smith Kline French Lab Process for preparing guanidine derivatives
GB1531231A (en) * 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives

Also Published As

Publication number Publication date
KE3373A (en) 1984-03-23
HK38284A (en) 1984-05-11
ES478203A1 (es) 1979-06-01
NO151824C (no) 1985-06-12
ES470474A1 (es) 1979-09-01
MY8500451A (en) 1985-12-31
SE8401492L (sv) 1984-03-16
FR2436138A1 (fr) 1980-04-11
NO152214C (no) 1985-08-28
FR2401143B1 (el) 1981-12-11
HU186766B (en) 1985-09-30
JPS5639313B2 (el) 1981-09-11
GB1598630A (en) 1981-09-23
MY8500452A (en) 1985-12-31
CY1229A (en) 1984-06-29
SE8401491L (sv) 1984-03-16
IL54819A0 (en) 1978-07-31
NO781928L (no) 1978-12-05
AR222797A1 (es) 1981-06-30
SG8584G (en) 1985-02-08
FR2401143A1 (fr) 1979-03-23
NO791637L (no) 1978-12-05
LU79725A1 (fr) 1979-02-02
NO833255L (no) 1978-12-05
YU215482A (en) 1983-02-28
NL7805935A (nl) 1978-12-05
CY1230A (en) 1984-06-29
SE7806525L (sv) 1978-12-04
IL54819A (en) 1983-03-31
CA1110251A (en) 1981-10-06
MY8500453A (en) 1985-12-31
IE781112L (en) 1978-12-03
DD140038A5 (de) 1980-02-06
SE443784B (sv) 1986-03-10
YU40625B (en) 1986-02-28
DK243178A (da) 1978-12-04
NZ187376A (en) 1981-05-29
YU40624B (en) 1986-02-28
JPS543067A (en) 1979-01-11
SE8401492D0 (sv) 1984-03-16
CY1231A (en) 1984-06-29
HK38084A (en) 1984-05-11
HK38184A (en) 1984-05-11
GB1598628A (en) 1981-09-23
IE47543B1 (en) 1984-04-18
FI69069B (fi) 1985-08-30
YU41620B (en) 1987-12-31
YU53079A (en) 1983-09-30
FR2436138B1 (el) 1982-12-03
GB1598629A (en) 1981-09-23
YU215582A (en) 1983-02-28
FI781737A (fi) 1978-12-04
CH641167A5 (en) 1984-02-15
GR73860B (el) 1984-05-08
ES478202A1 (es) 1979-06-01
YU129778A (en) 1983-02-28
SE8401491D0 (sv) 1984-03-16
DE2824066A1 (de) 1978-12-14
CH644591A5 (en) 1984-08-15
AR222503A1 (es) 1981-05-29
NO152214B (no) 1985-05-13
NO151824B (no) 1985-03-04

Similar Documents

Publication Publication Date Title
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
JPH058183B2 (el)
US4112234A (en) Imidazolylmethylthioethyl alkynyl guanidines
KR860002036B1 (ko) 히스타민 h₂-길항제의 제조방법
FI69069C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner
KR840001075B1 (ko) 티아졸 유도체의 제조방법
US4157347A (en) N-cyano isothioureas
KR910009213B1 (ko) 4,5,6,7-테트라하이드로티아졸로[5,4-c]피리딘 유도체의 제조방법
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
KR880002209B1 (ko) 치환된 3,4-디아미노-1,2,5-티아디아졸류 및 그의 제조방법
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
EP0180500A1 (fr) Dérivés de thiéno et furo - [2,3-c]pyrroles, procédés de préparation et médicaments les contenant
US4588826A (en) Ethanediimidamide intermediates
US4200760A (en) Imidazolylalkylthioalkylamino-ethylene derivatives
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
KR810000632B1 (ko) 히스타민 h₂수용기 길항제 또는 비독성인 그의 약조제 가능한 산 첨가염의 제조방법
US4595758A (en) Ethanediimidamide intermediates
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
CA1130306A (en) N-cyano-n'-[2-[(4-methyl-5-imidazolyl) methylthio]ethyl]- n"-alkynylguanidines h.sub.2 receptor blocking agents
USRE31588E (en) Imidazolylmethylthioethyl alkynyl guanidines
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
CA1142544A (en) N-cyano-n'-(2-[(4-methyl-5-imidazolyl) methylthio]ethyl) - n"-alkynylguanidines h.sub.2 receptor blocking agents
KR790001525B1 (ko) 치환된 인돌유도체의 제법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO